Thymidylate synthase (TYMS) is elevated in numerous tumors [30,31,32] and its overexpression corresponds to worsening clinical outcomes and has been correlated with drug resistance in malignant cells, including mesothelioma patients [3,5,33,34]. Here, TYMS is linked to mesothelioma.